115 related articles for article (PubMed ID: 38880888)
1. In-vitro evaluation of different antimicrobial combinations with and without colistin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
Müderris T; Dursun Manyaslı G; Sezak N; Kaya S; Demirdal T; Gül Yurtsever S
Eur J Med Res; 2024 Jun; 29(1):331. PubMed ID: 38880888
[TBL] [Abstract][Full Text] [Related]
2.
Soudeiha MAH; Dahdouh EA; Azar E; Sarkis DK; Daoud Z
Front Cell Infect Microbiol; 2017; 7():209. PubMed ID: 28596943
[TBL] [Abstract][Full Text] [Related]
3. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
Turk Dagi H; Kus H; Arslan U; Tuncer I
Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
[TBL] [Abstract][Full Text] [Related]
4. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an
Bian X; Liu X; Chen Y; Chen D; Li J; Zhang J
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745385
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic Analysis of Meropenem and Fosfomycin Combination Against Carbapenem-Resistant
Mohd Sazlly Lim S; Heffernan AJ; Roberts JA; Sime FB
Microb Drug Resist; 2021 Apr; 27(4):546-552. PubMed ID: 32898467
[No Abstract] [Full Text] [Related]
6. In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii.
Ju YG; Lee HJ; Yim HS; Lee MG; Sohn JW; Yoon YK
Sci Rep; 2022 May; 12(1):7541. PubMed ID: 35534512
[TBL] [Abstract][Full Text] [Related]
7. In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant
Oliva A; Garzoli S; De Angelis M; Marzuillo C; Vullo V; Mastroianni CM; Ragno R
Molecules; 2019 Mar; 24(5):. PubMed ID: 30832412
[TBL] [Abstract][Full Text] [Related]
8. [Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].
Ozseven AG; Sesli Çetin E; Ozseven L
Mikrobiyol Bul; 2012 Jul; 46(3):410-20. PubMed ID: 22951653
[TBL] [Abstract][Full Text] [Related]
9. Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii.
Bian X; Liu X; Feng M; Bergen PJ; Li J; Chen Y; Zheng H; Song S; Zhang J
Int J Antimicrob Agents; 2021 Feb; 57(2):106271. PubMed ID: 33352235
[TBL] [Abstract][Full Text] [Related]
10. In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates.
Hong DJ; Kim JO; Lee H; Yoon EJ; Jeong SH; Yong D; Lee K
Diagn Microbiol Infect Dis; 2016 Oct; 86(2):184-9. PubMed ID: 27475960
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of colistin monotherapy versus combination therapy with other antimicrobials against carbapenem-resistant
Li J; Fu Y; Zhang J; Zhao Y; Fan X; Yu L; Wang Y; Zhang X; Li C
J Chemother; 2020 Nov; 32(7):359-367. PubMed ID: 32427074
[TBL] [Abstract][Full Text] [Related]
12. Semi-mechanistic PK/PD modelling of meropenem and sulbactam combination against carbapenem-resistant strains of Acinetobacter baumannii.
Mohd Sazlly Lim S; Heffernan AJ; Zowawi HM; Roberts JA; Sime FB
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1943-1952. PubMed ID: 33884516
[TBL] [Abstract][Full Text] [Related]
13. Non-polymyxin-based combinations as potential alternatives in treatment against carbapenem-resistant Acinetobacter baumannii infections.
Mohd Sazlly Lim S; Naicker S; Ayfan AK; Zowawi H; Roberts JA; Sime FB
Int J Antimicrob Agents; 2020 Oct; 56(4):106115. PubMed ID: 32721600
[TBL] [Abstract][Full Text] [Related]
14. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
[TBL] [Abstract][Full Text] [Related]
15. [Various antibiotic combinations against carbapenem resistant Acinetobacter baumannii infections and in vitro synergy test results (2002-2016)].
Zarakolu P; Ayaz ÇM; Metan G
Mikrobiyol Bul; 2018 Apr; 52(2):190-197. PubMed ID: 29933736
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of In Vitro Efficacy of Ceftazidime-Avibactam, Meropenem, and Colistin Single and Binary Combinations Against Carbapenem Resistant Klebsiella pneumoniae Strains Isolated from Various Clinical Specimens].
Köle M; Sesli Çetin E; Şirin MC; Cicioğlu Arıdoğan B
Mikrobiyol Bul; 2022 Apr; 56(2):230-250. PubMed ID: 35477227
[TBL] [Abstract][Full Text] [Related]
17. Investigating the in vitro synergistic activities of several antibiotic combinationsagainst carbapenem-resistant Acinetobacter baumannii isolates.
Yavaş S; Yetkin MA; Kayaaslan B; Baştuğ A; Aslaner H; But A; Kanyilmaz D; Sari B; Akinci E; Bodur H
Turk J Med Sci; 2016 Apr; 46(3):892-6. PubMed ID: 27513270
[TBL] [Abstract][Full Text] [Related]
18. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of colistin in antimicrobial combination against carbapenem-resistant Acinetobacter baumannii isolated from patients with ventilator-associated pneumonia in Vietnam.
Le Minh V; Thi Khanh Nhu N; Vinh Phat V; Thompson C; Huong Lan NP; Thieu Nga TV; Thanh Tam PT; Tuyen HT; Hoang Nhu TD; Van Hao N; Thi Loan H; Minh Yen L; Parry CM; Trung Nghia HD; Campbell JI; Hien TT; Thwaites L; Thwaites G; Van Vinh Chau N; Baker S
J Med Microbiol; 2015 Oct; 64(10):1162-1169. PubMed ID: 26297024
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
Sheng WH; Wang JT; Li SY; Lin YC; Cheng A; Chen YC; Chang SC
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):380-6. PubMed ID: 21558048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
